Lv11
88 积分 2024-06-19 加入
Underlying Mechanisms and Treatment of Hypertension in Glomerular Diseases
2小时前
待确认
Long-Acting Factor XI Inhibition and Periprocedural Bleeding
3天前
已完结
Long-Acting Factor XI Inhibition and Periprocedural Bleeding
3天前
已完结
Modifications of coronary plaque phenotype on lipid-lowering therapies and risk of cardiovascular events: a systematic review and meta-regression analysis
20天前
已完结
The Lancet Commission on rethinking coronary artery disease: moving from ischaemia to atheroma
20天前
已完结
LDL-cholesterol, lipoprotein(a) and high-sensitivity low-density lipoprotein cholesterol, lipoprotein(a) and high-sensitivity C-reactive protein are independent predictors of cardiovascular events
24天前
已完结
Revascularization Strategies in ST-Segment Elevation Myocardial Infarction With Multivessel Disease
27天前
已关闭
Targeting Glomerular Hemodynamics for Kidney Protection
1个月前
已完结
ALIGNing the treatment of IgA nephropathy: Reducing proteinuria with endothelin A receptor inhibition
1个月前
已完结
Proteinuria as a Surrogate Outcome in CKD: Report of a Scientific Workshop Sponsored by the National Kidney Foundation and the US Food and Drug Administration
1个月前
已完结
Abstract 11117: Phase 1 Danon Disease Results: The First Single Dose Intravenous (IV) Gene Therapy (RP-A501) With Recombinant Adeno-Associated Virus (AAV9:LAMP2B) for a Monogenic Cardiomyopathy
皖公网安备34019202002308
